Clinical Characteristics of Patients (n = 102)
| Parameter | Variable | Number | Percentage |
|---|---|---|---|
| Sex | Female | 32 | 31.4% |
| Male | 70 | 68.6% | |
| Lymphoma type | Hodgkin | 80 | 78.4% |
| Non-Hodgkin | 22 | 21.6% | |
| Clinical final stage | 1 | 8 | 7.8% |
| 2 | 34 | 33.3% | |
| 3 | 34 | 33.3% | |
| 4 | 26 | 25.5% | |
| Spleen | Yes | 29 | 28.4% |
| Disease | No | 73 | 71.6% |
| Extranodal sites | 0 | 67 | 65.7% |
| 1 | 15 | 14.7% | |
| ≥2 | 20 | 19.6% | |
| Disease bulk | Bulky | 63 | 61.8% |
| Nonbulky | 39 | 38.2% | |
| B symptoms | Yes | 43 | 43.0% |
| No | 57 | 57.0% | |
| LDH | High | 47 | 52.8% |
| Normal | 42 | 47.2% | |
| Leukocytosis | Yes | 32 | 31.7% |
| No | 69 | 68.3% | |
| Erythrocyte sedimentation rate | Normal | 34 | 52.3% |
| Elevated | 31 | 47.7% | |
| Anemia | Yes | 47 | 47.5% |
| No | 52 | 52.5% | |
| Albumin | Yes | 27 | 37.0% |
| No | 46 | 63.0% | |
| Bone marrow | Diffuse | 12 | 11.9% |
| 18F-FDG | Focal | 16 | 15.8% |
| Uptake | Negative | 73 | 72.3% |
| Event | Yes | 10 | 9.8% |
| No | 92 | 90.2% | |
| Status | Alive | 101 | 99.0% |
| Dead | 1 | 1.0% |